Ticagrelor showed greater antiplatelet efficacy than clopidogrel in diabetic patients post-PCI

2020.09.07

Clopidogrel is currently the only P2Y12 inhibitor with class I recommendation in patients after percutaneous coronary intervention (PCI) for chronic coronary syndromes (CCS). However, it is noted...

Mid-range ejection fraction in STEMI patients linked to higher adverse outcomes

2020.08.31

Evidence is sparse on the impact of mid-range ejection fraction (mrEF) on clinical outcomes including ventricular arrhythmias and in ST-segment-elevation myocardial infarction (STEMI). Therefore, a...